Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Adenomatous Polyposis Coli × Sulindac × Clear all

Phase

Status

Completed 2 Withdrawn 1 Unknown 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pathologic Complete Response 1 Neoplasms 1 Leukemia, Myeloid, Acute 1 Colonic Polyps 1 Adenomatous Polyposis Coli 1

Interventions

Sulindac 1 Eflornithine 1 Curcumin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01245816 2015-04-24

A Trial of Low Dose Sulindac Combined With Eflornithine in Patients With Familial Adenomatous Polyposis (FAP)

Cancer Prevention Pharmaceuticals, Inc.

Phase 3 Withdrawn

Gastrointestinal

Colonic Polyps, Adenomatous Polyposis Coli

Data powered by HemOnc (CC BY 4.0) Colophon ⚡